Menu

Scientists Successfully Transplant Human Leukemia Cells into Mice

While studying the progression of healthy cells into cancerous ones, researchers discover a way to engraft human blood cells into animals.

Apr 1, 2017
Diana Kwon

TRANSFORMATIONS: An artistic representation of cancer progression in a cell, from normal to a leukemic state (from left to right)LEWIS LONG

EDITOR'S CHOICE IN CANCER BIOLOGY

The paper
A.G. Kotini et al., “Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia,” Cell Stem Cell, 20:315-28.e7, 2017.

Cancer continuum
In recent years, cancer researchers have discovered that myeloid malignancies lie on a continuum of increasing severity, starting as precancerous mutations in blood cell precursors, then progressing to bone marrow disorders, and, finally, developing into acute myeloid leukemia.

Transitions
Eirini Papapetrou of the Icahn School of Medicine at Mount Sinai and colleagues followed disease progression by reprogramming cells from patients with various stages of myeloid malignancies, including premalignant cells, into pluripotent stem cells in their precancerous state. Then, by differentiating them back into blood cells, the team established cell lines representing specific stages of disease. “What we want to do now is understand the exact molecular/cellular events that drive the stepwise progression from normal cells to leukemic cells,” says Papapetrou.

Transplants  
The researchers discovered that when they converted full-blown leukemia cells into stem cells and back into blood, they could transplant them into mice—a feat that had not been accomplished before with human blood cancer. “One of the holy grails of blood stem cell research is the ability to produce transplantable stem cells,” says Stanford University’s Ravindra Majeti, whose group concurrently reported transplantable leukemic cells using a similar approach (Cell Stem Cell, 20:329-44.e7, 2017). “It is one of the big hurdles limiting the translational applications for blood disease.”

Solving the puzzle
“One of the future goals is to figure out what it is that really can drive an engraftable cell,” says Papapetrou’s coauthor, Michael Kharas of Memorial Sloan Kettering Cancer Center. “We think that the leukemia-derived cells were able to maintain or acquire some aspect of the blood stem cell program that was not in the other cell types.”

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Immunophenotypic Analysis of Human Blood Leukocyte Subsets

Download this application note from ACEA Biosciences, Inc., to find out how to perform an immunophenotypic analysis of a human blood sample utilizing 13 fluorescent markers using a compact benchtop flow cytometer equipped with 3 lasers!